熱門資訊> 正文
Reviva Pharmaceuticals GAAP每股收益为-0.06美元
2025-11-14 05:59
- Reviva Pharmaceuticals Holdings Inc. Warrants (25/12/2025)(RVPHW) 0
- Reviva Pharmaceuticals Holdings, Inc.(RVPH) 0
- Reviva Pharmaceuticals press release (RVPH): Q3 GAAP EPS of -$0.06.
- As of September 30, 2025, the Company’s cash and cash equivalents totaled approximately $13.2 million compared to approximately $13.5 million as of December 31, 2024.
More on Reviva Pharmaceuticals
- Reviva Pharmaceuticals announces pricing of $9M public offering
- Reviva Pharmaceuticals announces proposed public offering
- Seeking Alpha’s Quant Rating on Reviva Pharmaceuticals
- Historical earnings data for Reviva Pharmaceuticals
- Financial information for Reviva Pharmaceuticals
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
